{
  "success": true,
  "enriched": 43,
  "total_entities": 460,
  "by_type": {
    "StudyArm": 2,
    "EligibilityCriterion": 33,
    "Objective": 4,
    "Endpoint": 4
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "LY900018 3 mg",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Intramuscular Glucagon 1 mg",
      "arm_type": "Active Comparator Arm",
      "nci_code": "C174267"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Diagnosis of T1DM or T2DM",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Contraception for male patients",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Requirements for female patients",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Age requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Body mass index requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hemoglobin A1c value",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Clinical laboratory test results",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Venous access",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Willingness to participate",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed consent",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Investigative site personnel affiliation",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Lilly employees",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Current enrollment in other clinical tri",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recent participation in other clinical t",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Previous participation in LY900018 studi",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Known allergies or sensitivity",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "ECG abnormality",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Significant changes in insulin regimen",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "High total daily dose of insulin",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Poorly controlled hypertension",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of pheochromocytoma or insulinom",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of severe hypoglycemia or loss o",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of epilepsy or seizure disorder",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of significant disorders",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Known or ongoing psychiatric disorders",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Use of drugs of abuse",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Evidence of HIV infection",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Evidence of hepatitis C",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Evidence of hepatitis B",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Evidence of syphilis",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Lactating women",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Use of specific medications",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recent blood donation",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Safety and Tolerability",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Pharmacokinetics",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Pharmacodynamics",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Endpoint",
      "name": "Primary Efficacy Endpoint",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Safety and Tolerability Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Pharmacokinetic Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Pharmacodynamic Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 50,
    "stale_entries": 0,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}